Forte Biosciences, Inc. (FBRX) Financials
FBRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 47.9 million | 7.5 million |
2023-06-30 | 31.2 million | 6.3 million |
2023-03-31 | 36.7 million | 3.8 million |
2022-12-31 | 42.0 million | 3.2 million |
FBRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -9.1 million | 772000 |
2023-06-30 | -5.5 million | 855000 |
2023-03-31 | -5.2 million | 877000 |
2022-12-31 | -2.9 million | 860000 |
FBRX Net Income
No data available :(
FBRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 46.2 million | - | - |
2023-06-30 | 30.4 million | - | - |
2023-03-31 | 35.9 million | - | - |
2022-12-31 | 41.1 million | - | - |
FBRX Shares Outstanding
FBRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 71000 | 6.4 million | 3.8 million | - |
2023-06-30 | - | 7.1 million | 1.9 million | - |
2023-03-31 | - | 4.8 million | 2.1 million | - |
2022-12-31 | - | 2.5 million | 2.5 million | - |
FBRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 3000 |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
FBRX
Price: $0.68
52 week price:
Earnings Per Share: -1.00 USD
P/E Ratio: -0.52
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 50864
Market Capitalization: 26.2 million